Additionally, considering that Epac1 and Epac2 isoforms exert, respectively, anti-apoptotic [55] and pro-apoptotic effects in lung cancer, it would also be of interest to study antagonistic or synergistic roles that the two isoforms may play in the other cancer types. This evidence concerns the gene RAPGEF3 and lung cancer.